Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04017130 |
Title | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Millennium Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Southern California | Los Angeles | California | 90033 | United States | Details | |
Mayo Clinic - Jacksonville | Jacksonville | Florida | 32224 | United States | Details | |
Miami University | Miami | Florida | 33136 | United States | Details | |
Northside Hospital | Atlanta | Georgia | 30342 | United States | Details | |
Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | United States | Details | |
The Ohio State University | Columbus | Ohio | 43201 | United States | Details | |
Vanderbilt University Medical Center- Ingram Cancer Center | Nashville | Tennessee | 37203 | United States | Details |